Open this publication in new window or tab >>Animal Science and Technology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK; Department of Radiology, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Pathology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.
Safety Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
KTH, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Gene Technology. KTH, Centres, Science for Life Laboratory, SciLifeLab.
KTH, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Gene Technology. KTH, Centres, Science for Life Laboratory, SciLifeLab.
Pathology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Safety Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
Safety Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
KTH, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Gene Technology. KTH, Centres, Science for Life Laboratory, SciLifeLab.
Safety Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
Predictive AI & Data, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK.
Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Show others...
(English)Manuscript (preprint) (Other academic)
Abstract [en]
Recent developments in spatially resolved omics have expanded studies linking gene expression, epigenetic alterations, protein levels, and metabolite intensity to tissue histology. The integration of multiple spatial measurements can offer new insights into alterations propagating across modalities, however, it also presents experimental and computational challenges.
To set the multimodal data into a shared coordinate system for enhanced integration and analysis, we propose MAGPIE, a framework for co-registering spatially resolved transcriptomics and spatial metabolomics measurements on the same or consecutive tissue sections, present within their existing histological context. Further, we showcase the utility of the MAGPIE framework on spatial multi-omics data from lung tissue, an inherently heterogeneous tissue type with integrity challenges and for which we developed an experimental sampling strategy to allow multimodal data generation. In these case studies, we were able to link pharmaceutical co-detection with endogenous responses in rat lung tissue following inhalation of a small molecule, which had previously been stopped during preclinical development with findings of lung irritation, and to characterise the metabolic and transcriptomic landscape in a mouse model of drug-induced pulmonary fibrosis in conjunction with histopathology annotations.
The generalisability and scalability of the MAGPIE framework were further benchmarked on public datasets from multiple species and tissue types, demonstrating applicability to both DESI and MALDI mass spectrometry imaging together with Visium-enabled transcriptomic assessment. MAGPIE highlights the refined resolution and increased interpretability of spatial multimodal analyses in studying tissue injury, particularly in a pharmacological context, and offers a modular, accessible computational workflow for data integration.
Keywords
Spatially resolved transcriptomics, Visium, Mass Spectrometry Imaging, Histology, Multi-omics, Pipeline, Data analysis, Data integration
National Category
Bioinformatics (Computational Biology) Cell and Molecular Biology
Research subject
Biotechnology
Identifiers
urn:nbn:se:kth:diva-354731 (URN)
Funder
AstraZenecaSwedish Foundation for Strategic Research
Note
QC 20241016
2024-10-112024-10-112024-10-16Bibliographically approved